Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Primary Ciliary Dyskinesia Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 49 | 37 |
|
Primary Ciliary Dyskinesia (PCD) via the DNAH5 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 135 | 133 |
|
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome and Cystic Fibrosis Panel PreventionGenetics, part of Exact Sciences United States | 44 | 51 |
|
Complete panel of pulmonology. NGS panel of 66 genes. Genologica Medica Spain | 115 | 66 |
|
Bronchiectasis panel. NGS panel of 15 genes. Genologica Medica Spain | 19 | 15 |
|
Plugin system clutter panel. NGS panel of 75 genes. Genologica Medica Spain | 76 | 75 |
|
Ciliary dyskinesia and heterotaxia. NGS panel of 40 genes. Genologica Medica Spain | 49 | 40 |
|
Primary ciliary dyskinesia panel. 36-gene NGS panel. Genologica Medica Spain | 46 | 35 |
|
Heterotaxy and situs inversus panel. 32-gene NGS panel. Genologica Medica Spain | 34 | 31 |
|
DNAH5 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
Natera, Inc. United States | 244 | 254 |
|
Natera, Inc. United States | 103 | 106 |
|
Natera, Inc. United States | 103 | 106 |
|
Natera, Inc. United States | 265 | 274 |
|
Natera, Inc. United States | 265 | 274 |
|
Natera, Inc. United States | 265 | 274 |
|
Primary Ciliary Dyskinesia Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 30 | 20 |
|
Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 64 | 66 |
|
Primary Ciliary Dyskinesia panel Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 36 | 38 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.